ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

Recompetitions Of DCT Contracts Okayed

March 3, 1989

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

“Official Chronology” Of Gall/Montagnier Finding Agreed On; Royalties to Fund AIDS research

April 10, 1987

Funding Opportunities listed.

May 21, 2004